Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Novo Nordisk Drops on Weight-Loss Study by Rival Lilly

In This Article:

Novo Nordisk slumped after a pill from rival Eli Lilly helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. Bloomberg Intelligence's Sam Fazeli explains.